ZA983629B - Serine protease inhibitors - Google Patents

Serine protease inhibitors

Info

Publication number: ZA983629B
Authority: ZA; South Africa
Prior art keywords: protease inhibitors; serine protease; serine; inhibitors; protease
Prior art date: 1997-05-02

Application number

ZA983629A

Other languages

English (en)

Inventor

Anton Egbert Peter Adang

Original Assignee

Akzo Nobel Nv

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-05-02

Filing date

1998-04-29

Publication date

1998-11-04

1998-04-29 Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv

1998-11-04 Publication of ZA983629B publication Critical patent/ZA983629B/xx

Links

239000003001 serine protease inhibitor Substances 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
- C07K5/0202—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-X-X-C(=0)-, X being an optionally substituted carbon atom or a heteroatom, e.g. beta-amino acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
General Chemical & Material Sciences (AREA)
Public Health (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Genetics & Genomics (AREA)
Biochemistry (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Molecular Biology (AREA)
Biophysics (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Crystallography & Structural Chemistry (AREA)
Hematology (AREA)
Oncology (AREA)
Urology & Nephrology (AREA)
Diabetes (AREA)
Vascular Medicine (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)
Enzymes And Modification Thereof (AREA)

ZA983629A 1997-05-02 1998-04-29 Serine protease inhibitors ZA983629B (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
EP97201286		1997-05-02

Publications (1)

Publication Number	Publication Date
ZA983629B true ZA983629B (en)	1998-11-04

Family

ID=8228278

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ZA983629A ZA983629B (en)	1997-05-02	1998-04-29	Serine protease inhibitors

Country Status (23)

Country	Link
US (1)	US6534495B1 (id)
EP (1)	EP0979240B1 (id)
JP (1)	JP2001524117A (id)
KR (1)	KR20010012174A (id)
CN (1)	CN1254345A (id)
AR (1)	AR012631A1 (id)
AT (1)	ATE264339T1 (id)
AU (1)	AU729910B2 (id)
BR (1)	BR9809342A (id)
CA (1)	CA2287569A1 (id)
DE (1)	DE69823178T2 (id)
DK (1)	DK0979240T3 (id)
ES (1)	ES2218827T3 (id)
HU (1)	HUP0002942A3 (id)
ID (1)	ID22904A (id)
NO (1)	NO995316D0 (id)
NZ (1)	NZ500620A (id)
PL (1)	PL336589A1 (id)
PT (1)	PT979240E (id)
RU (2)	RU2183642C2 (id)
TR (1)	TR199902692T2 (id)
WO (1)	WO1998050420A1 (id)
ZA (1)	ZA983629B (id)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SE9900043D0 (sv) *	1999-01-11	1999-01-11	Astra Ab	New use
KR20010101355A (ko)	1999-01-02	2001-11-14	로버트 흐라이탁, 미쉘 베스트	신규한 말론산 유도체, 이의 제조 방법, 이의 용도 및이를 함유하는 약제학적 조성물(인자 ｘａ 활성 억제)
US6344450B1 (en) *	1999-02-09	2002-02-05	Bristol-Myers Squibb Company	Lactam compounds and their use as inhibitors of serine proteases and method
AU3731400A (en)	1999-03-05	2000-09-21	Trustees Of University Technology Corporation, The	Methods and compositions useful in inhibiting apoptosis
US6723711B2 (en)	1999-05-07	2004-04-20	Texas Biotechnology Corporation	Propanoic acid derivatives that inhibit the binding of integrins to their receptors
AU4826900A (en) *	1999-05-07	2000-11-21	Texas Biotechnology Corporation	Propanoic acid derivatives that inhibit the binding of integrins to their receptors
US6458952B1 (en)	1999-05-19	2002-10-01	Pharmacia Corporation	Substituted polycyclic aryl and heteroaryl uracils useful for selective inhibition of the coagulation cascade
US6664255B1 (en)	1999-05-19	2003-12-16	Pharmacia Corporation	Substituted polycyclic aryl and heteroaryl pyrazinones useful for selective inhibition of the coagulation cascade
US6716838B1 (en)	1999-05-19	2004-04-06	Pharmacia Corporation	Substituted polycyclic aryl and heteroaryl uracils as anticoagulative agents
US6653316B1 (en)	1999-05-19	2003-11-25	Pharmacia Corporation	Substituted polycyclic aryl and heteroaryl pyrimidinones useful for selective inhibition of the coagulation cascade
US7015230B1 (en)	1999-05-19	2006-03-21	Pharmacia Corporation	Substituted polycyclic aryl and heteroaryl uracils useful for selective inhibition of the coagulation cascade
US6867217B1 (en)	1999-05-19	2005-03-15	Pharmacia Corporation	Substituted polycyclic aryl and heteroaryl pyridones useful for selective inhibition of the coagulation cascade
US6750342B1 (en)	1999-05-19	2004-06-15	Pharmacia Corporation	Substituted polycyclic aryl and heteroaryl pyrimidinones useful for selective inhibition of the coagulation cascade
JP2000344739A (ja)	1999-06-01	2000-12-12	Sumitomo Chem Co Ltd	Ｎ−保護−アゼチジン−２−カルボン酸の製造方法
WO2001040262A1 (en) *	1999-12-03	2001-06-07	Bristol-Myers Squibb Pharma Company	Alpha-ketoamide inhibitors of hepatitis c virus ns3 protease
EP1127884A1 (en)	2000-02-26	2001-08-29	Aventis Pharma Deutschland GmbH	Novel malonic acid derivatives, processes for their preparation, their use as inhibitor of factor XA activity and pharmaceutical compositions containing them
US6660885B2 (en)	2000-03-13	2003-12-09	Pharmacia Corporation	Polycyclic aryl and heteroaryl substituted benzenes useful for selective inhibition of the coagulation cascade
WO2001077079A2 (en)	2000-04-05	2001-10-18	Pharmacia Corporation	Polycyclic aryl and heteroaryl substituted 4-pyridones useful for selective inhibition of the coagulation cascade
CA2405561A1 (en)	2000-04-05	2001-10-18	Pharmacia Corporation	Polycyclic aryl and heteroaryl substituted 4-pyrones useful for selective inhibition of the coagulation cascade
JP2004501077A (ja)	2000-04-17	2004-01-15	ファルマシア・コーポレーション	凝固カスケードの選択的阻害に有用な多環式アリールおよびヘテロアリール置換１，４−キノン
US7015223B1 (en)	2000-11-20	2006-03-21	Pharmacia Corporation	Substituted polycyclic aryl and heteroaryl 1,2,4-triazinones useful for selective inhibition of the coagulation cascade
JP2004517074A (ja)	2000-11-20	2004-06-10	ファルマシア・コーポレーション	凝血カスケードを選択的に阻害するのに有用な置換された多環アリールおよびヘテロアリールピリジン類
US7119094B1 (en)	2000-11-20	2006-10-10	Warner-Lambert Company	Substituted polycyclic aryl and heteroarpyl pyrazinones useful for selective inhibition of the coagulation cascade
HUP0304058A2 (hu)	2001-01-30	2004-04-28	Bristol-Myers Squibb Company	Xa faktor szulfonamid-laktám inhibitorok és alkalmazásuk és ezeket tartalmazó gyógyszerkészítmények
GB0119370D0 (en) *	2001-08-08	2001-10-03	Univ London	Therapeutic agent
ATE361068T1 (de)	2001-08-08	2007-05-15	Pentraxin Therapeutics Ltd	Wirkstoff zur entfernung einer unerwünschten proteinpopulation aus dem plasma
BR0213092A (pt)	2001-10-03	2004-10-19	Pharmacia Corp	Compostos heterocìclicos de 6 elementos úteis para a inibição seletiva da cascata de coagulação
CA2462645A1 (en)	2001-10-03	2003-11-13	Pharmacia Corporation	Substituted 5-membered polycyclic compounds useful for selective inhibition of the coagulation cascade
GB0313386D0 (en)	2003-06-10	2003-07-16	Univ London	Treatment of disease
PL2520654T3 (pl)	2003-08-26	2017-08-31	The Regents Of The University Of Colorado, A Body Corporate	Inhibitory aktywności proteazy serynowej i ich zastosowanie w sposobach i kompozycjach do leczenia zakażeń bakteryjnych
JP2007514742A (ja) *	2003-12-18	2007-06-07	アストラゼネカアクチボラグ	トロンビンの阻害薬として有用な新規５，６−ジヒドロピリジン−２−オン化合物
US7951823B2 (en)	2006-05-23	2011-05-31	Irm Llc	Compounds and compositions as channel activating protease inhibitors
KR20090108131A (ko)	2007-02-09	2009-10-14	아이알엠 엘엘씨	채널 활성화 프로테아제 억제제로서의 화합물 및 조성물
KR20120093754A (ko)	2009-03-10	2012-08-23	메드 디스커버리 에스에이	세린 프로테아제 저해제의 호중구감소증 치료에서의 용도
AU2019242595A1 (en) *	2018-03-28	2020-11-19	Blade Therapeutics, Inc.	Method of treating fibrotic disease
DE102020103516B4 (de)	2020-02-11	2023-12-07	Universität Zu Lübeck	Antivirale Wirkstoffe mit breiter Aktivität

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ZA86746B (en) *	1985-02-04	1986-09-24	Merrell Dow Pharma	Novel peptidase inhibitors
GB8728561D0 (en) *	1987-12-07	1988-01-13	Glaxo Group Ltd	Chemical compounds
US5919765A (en) *	1995-06-07	1999-07-06	Cor Therapeutics, Inc.	Inhibitors of factor XA
IL119466A (en) *	1995-11-03	2001-08-26	Akzo Nobel Nv	Thrombin inhibitors, their preparation and pharmaceutical compositions containing them
WO1998009987A1 (en) *	1996-09-06	1998-03-12	Biochem Pharma, Inc.	Lactam inhibitors of thrombin

1998
- 1998-04-28 PL PL98336589A patent/PL336589A1/xx unknown
- 1998-04-28 PT PT98924265T patent/PT979240E/pt unknown
- 1998-04-28 AT AT98924265T patent/ATE264339T1/de not_active IP Right Cessation
- 1998-04-28 DE DE69823178T patent/DE69823178T2/de not_active Expired - Fee Related
- 1998-04-28 JP JP54771598A patent/JP2001524117A/ja active Pending
- 1998-04-28 ID IDW991290A patent/ID22904A/id unknown
- 1998-04-28 HU HU0002942A patent/HUP0002942A3/hu unknown
- 1998-04-28 CA CA002287569A patent/CA2287569A1/en not_active Abandoned
- 1998-04-28 US US09/403,856 patent/US6534495B1/en not_active Expired - Fee Related
- 1998-04-28 TR TR1999/02692T patent/TR199902692T2/xx unknown
- 1998-04-28 CN CN98804741A patent/CN1254345A/zh active Pending
- 1998-04-28 EP EP98924265A patent/EP0979240B1/en not_active Expired - Lifetime
- 1998-04-28 DK DK98924265T patent/DK0979240T3/da active
- 1998-04-28 RU RU99125967/04A patent/RU2183642C2/ru active
- 1998-04-28 KR KR19997010123A patent/KR20010012174A/ko not_active Withdrawn
- 1998-04-28 NZ NZ500620A patent/NZ500620A/xx unknown
- 1998-04-28 AU AU76520/98A patent/AU729910B2/en not_active Ceased
- 1998-04-28 BR BR9809342-8A patent/BR9809342A/pt not_active IP Right Cessation
- 1998-04-28 ES ES98924265T patent/ES2218827T3/es not_active Expired - Lifetime
- 1998-04-28 WO PCT/EP1998/002587 patent/WO1998050420A1/en not_active Ceased
- 1998-04-29 ZA ZA983629A patent/ZA983629B/xx unknown
- 1998-04-30 AR ARP980102014A patent/AR012631A1/es unknown
1999
- 1999-11-01 NO NO995316A patent/NO995316D0/no not_active Application Discontinuation
2002
- 2002-02-14 RU RU2002104026/15A patent/RU2002104026A/ru not_active Application Discontinuation

Also Published As

Publication number	Publication date
PL336589A1 (en)	2000-07-03
AU729910B2 (en)	2001-02-15
RU2002104026A (ru)	2004-04-27
BR9809342A (pt)	2000-07-04
JP2001524117A (ja)	2001-11-27
PT979240E (pt)	2004-08-31
DE69823178D1 (de)	2004-05-19
DE69823178T2 (de)	2005-06-23
CN1254345A (zh)	2000-05-24
EP0979240A1 (en)	2000-02-16
KR20010012174A (ko)	2001-02-15
CA2287569A1 (en)	1998-11-12
EP0979240B1 (en)	2004-04-14
AR012631A1 (es)	2000-11-08
WO1998050420A1 (en)	1998-11-12
NZ500620A (en)	2000-10-27
ID22904A (id)	1999-12-16
US6534495B1 (en)	2003-03-18
ES2218827T3 (es)	2004-11-16
RU2183642C2 (ru)	2002-06-20
NO995316L (no)	1999-11-01
DK0979240T3 (da)	2004-07-26
NO995316D0 (no)	1999-11-01
TR199902692T2 (xx)	2000-07-21
HUP0002942A2 (hu)	2001-01-29
ATE264339T1 (de)	2004-04-15
HUP0002942A3 (en)	2001-12-28
AU7652098A (en)	1998-11-27

Publication	Publication Date	Title
IL131661A0 (en)	2001-01-28	Protease inhibitors
AU7127298A (en)	1998-11-11	Serine protease inhibitors
PL336589A1 (en)	2000-07-03	Serinic protease inhibitors
PL349192A1 (en)	2002-07-01	Protease inhibitors
HUP9901187A3 (en)	1999-11-29	Serine protease inhibitors
PL347948A1 (en)	2002-04-22	Serine protease inhibitor
PL337755A1 (en)	2000-09-11	Protease inhibitors
NZ331486A (en)	1999-07-29	Serine protease inhibitors
IL132629A0 (en)	2001-03-19	Protease inhibitors
PL336856A1 (en)	2000-07-17	Protease inhibitors
EP1093367A4 (en)	2003-03-05	PROTEASE INHIBITORS
ZA971667B (en)	1997-09-10	Serine protease inhibitors.
ZA988479B (en)	1998-10-26	Protease inhibitors
EP1067894A4 (en)	2004-09-08	PROTHEASEINHIBITOREN
EP1079821A4 (en)	2001-08-29	PROTEASE INHIBITORS
GB9800817D0 (en)	1998-03-11	Serine protease inhibitors
ZA988064B (en)	1999-05-28	Protease inhibitors
GB9603217D0 (en)	1996-04-17	Serine protease inhibitors
EP1140897A4 (en)	2002-04-03	PROTEASE INHIBITORS
EP1086083A4 (en)	2001-09-26	PROTEASE INHIBITORS
EP0975612A4 (en)	2001-06-13	PROTEASE INHIBITORS
GB9613719D0 (en)	1996-08-28	Serine protease inhibitors
HK1024005A (en)	2000-09-29	Serine protease inhibitors
ZA983097B (en)	1998-10-15	Protease inhibitors
ZA971178B (en)	1997-09-03	Serine protease inhibitors.